Westlake Chemical Partners LP - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Westlake Chemical Partners LP on August 31, 2026. The filing discloses a change in senior management personnel within the Partnership's General Partner and its indirect parent company, Westlake Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Tommy E. Darby as Vice President, Chief Accounting Officer of Westlake Chemical Partners GP LLC and Westlake Corporation, effective August 31, 2026. Concurrently, Jeffrey A. Holy is transitioning from Chief Accounting Officer to Vice President, Finance and Investor Relations of the General Partner.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. It confirms there are no family relationships between the new appointee and existing directors or officers, and no undisclosed arrangements regarding his appointment.
Key Facts for Investor Verification
- Tommy E. Darby was appointed Vice President, Chief Accounting Officer effective August 31, 2026.
- Jeffrey A. Holy is moving to the role of Vice President, Finance and Investor Relations.
- Mr. Darby previously served as Chief Accounting Officer at Pactiv Evergreen Inc. (now Novolex) from 2022 to 2025.
- Mr. Darby holds a CPA and degrees from the University of North Texas.
- No financial metrics or operational updates are included in this specific filing.